These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20602736)

  • 1. Serotonin syndrome caused by ziprasidone alone.
    Lin PY; Hong CJ; Tsai SJ
    Psychiatry Clin Neurosci; 2010 Jun; 64(3):338-9. PubMed ID: 20602736
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible serotonin syndrome with citalopram following cross-titration of clozapine to ziprasidone.
    Kinzie E; Meltzer-Brody S
    Gen Hosp Psychiatry; 2005; 27(3):223-4. PubMed ID: 15882772
    [No Abstract]   [Full Text] [Related]  

  • 3. Ziprasidone, monoamine oxidase inhibitors, and the serotonin syndrome.
    Rim CL; Gitlin MJ
    J Clin Psychopharmacol; 2010 Aug; 30(4):470-1. PubMed ID: 20631570
    [No Abstract]   [Full Text] [Related]  

  • 4. Serotonin syndrome after the use of tramadol and ziprasidone in a patient with a deep brain stimulator for Parkinson disease.
    El-Okdi NS; Lumbrezer D; Karanovic D; Ghose A; Assaly R
    Am J Ther; 2014; 21(4):e97-9. PubMed ID: 24158007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: a diagnostic challenge.
    Gray NS
    Hum Psychopharmacol; 2004 Apr; 19(3):205-7. PubMed ID: 15079855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ziprasidone-induced hypersensitivity syndrome in an aged schizophrenia patient.
    Tsai CF; Tsai SJ; Hwang JP
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):797-9. PubMed ID: 16035110
    [No Abstract]   [Full Text] [Related]  

  • 7. The potential relationship between QTc interval prolongation and ziprasidone treatment: three cases.
    Eker SS; Sarandol A; Akkaya C; Sivrioglu EY; Kirli S
    J Psychopharmacol; 2009 Nov; 23(8):993-6. PubMed ID: 18635710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The highest intentional ziprasidone overdose was not fatal.
    Prieto T; Benabarre A; Bernardo M
    Acta Psychiatr Scand; 2005 Jul; 112(1):79-80; author reply 80. PubMed ID: 15952953
    [No Abstract]   [Full Text] [Related]  

  • 9. Ziprasidone-associated galactorrhea in a female teenager.
    Jordan MP
    J Am Acad Child Adolesc Psychiatry; 2003 Jan; 42(1):4-5. PubMed ID: 12500070
    [No Abstract]   [Full Text] [Related]  

  • 10. Ziprasidone-induced hyperprolactinemia: a case report.
    Citil DY; Selçuk E; Karlidağ R; Unal S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):905-6. PubMed ID: 18276052
    [No Abstract]   [Full Text] [Related]  

  • 11. Possible ziprasidone-induced mania.
    Larson MF; Hauser A
    J Am Acad Child Adolesc Psychiatry; 2003 Sep; 42(9):1012; discussion 1012-3. PubMed ID: 12964565
    [No Abstract]   [Full Text] [Related]  

  • 12. Inadvertent administration of intravenous ziprasidone leading to bradycardia and QT interval prolongation.
    Bentley ML; Biscardi FH; Butcher C; Levitov A
    Ann Pharmacother; 2008 Jun; 42(6):902-3. PubMed ID: 18477728
    [No Abstract]   [Full Text] [Related]  

  • 13. Parkinsonism with intramuscular ziprasidone.
    Bilal L; Tsai C; Gasper JJ; Ndlela JC
    Am J Psychiatry; 2005 Dec; 162(12):2392-3. PubMed ID: 16330610
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ziprasidone and dementia].
    Aakhus E
    Tidsskr Nor Laegeforen; 2004 Aug; 124(16):2155-6; author reply 2155-6. PubMed ID: 15334150
    [No Abstract]   [Full Text] [Related]  

  • 15. Ziprasidone and mania.
    Barnett MS
    J Am Acad Child Adolesc Psychiatry; 2004 Apr; 43(4):380. PubMed ID: 15187796
    [No Abstract]   [Full Text] [Related]  

  • 16. Ziprasidone-induced acute dystonia.
    Mason MN; Johnson CE; Piasecki M
    Am J Psychiatry; 2005 Mar; 162(3):625-6. PubMed ID: 15741487
    [No Abstract]   [Full Text] [Related]  

  • 17. Sudden death in a patient with Tourette syndrome during a clinical trial of ziprasidone.
    Scahill L; Blair J; Leckman JF; Martin A
    J Psychopharmacol; 2005 Mar; 19(2):205-6. PubMed ID: 15728441
    [No Abstract]   [Full Text] [Related]  

  • 18. High-dose ziprasidone-induced acute dystonia.
    Rosenfield PJ; Girgis RR; Gil R
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):546-7. PubMed ID: 17123682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ziprasidone-induced acute laryngeal dystonia.
    Duggal HS
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):970; author reply 971. PubMed ID: 17343967
    [No Abstract]   [Full Text] [Related]  

  • 20. Ziprasidone-induced oculogyric crisis.
    Ramos AE; Shytle RD; Silver AA; Sanberg PR
    J Am Acad Child Adolesc Psychiatry; 2003 Sep; 42(9):1013-4. PubMed ID: 12964566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.